Apixaban vs Dual Antiplatet Therapy Study After Left Atrial Appendage Occlosure (ADALA)
NCT05632445
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
160
Enrollment
OTHER
Sponsor class
Conditions
Left Atrial Appendage Occlusion
Interventions
DRUG:
Apixaban vs. DAPT
Sponsor
DR. XAVIER FREIXA